Page last updated: 2024-08-05 11:55:23
rutinoside
null
ChEBI ID: 26587
Members (8)
| Member | Definition | Role |
|---|---|---|
| diosmin | A disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | diosmin |
| eriocitrin | A disaccharide derivative that consists of eriodictyol substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | eriocitrin |
| hesperidin | A disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | hesperidin |
| isonaringin | A disaccharide derivative that is (S)-naringenin substituted by a 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | narirutin |
| kaempferol-3-o-rutinoside | A kaempferol O-glucoside that is kaempferol attached to a rutinosyl [6-deoxy-alpha-L-mannosyl-(1->6)-beta-D-glucosyl] residue at position 3 via a glycosidic linkage. It has been isolated from the leaves of Solanum campaniforme. | kaempferol-3-rutinoside |
| methyl hesperidin | A flavanone glycoside that is hesperidin in which the hydroxy group at position 3' has been replaced by a methoxy group. | methyl hesperidin |
| pectolinarin | A disaccharide derivative that consists of pectolinarigenin substituted by a 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | pectolinarin |
| rutin | A rutinoside that is quercetin with the hydroxy group at position C-3 substituted with glucose and rhamnose sugar groups. | rutin |
Research
Studies (6,023)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1,200 (19.92) | 18.7374 |
| 1990's | 371 (6.16) | 18.2507 |
| 2000's | 1,040 (17.27) | 29.6817 |
| 2010's | 2,263 (37.57) | 24.3611 |
| 2020's | 1,149 (19.08) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 472 (6.97%) | 5.53% |
| Reviews | 283 (4.18%) | 6.00% |
| Case Studies | 48 (0.71%) | 4.05% |
| Observational | 14 (0.21%) | 0.25% |
| Other | 5,953 (87.93%) | 84.16% |